1887

Abstract

Hepatitis B virus (HBV) X antigen (HBxAg) may contribute to the development of hepatocellular carcinoma (HCC) by activation of signalling pathways such as NF-B. To identify NF-B target genes differentially expressed in HBxAg-positive compared to -negative cells, HepG2 cells consistently expressing HBxAg (HepG2X cells) were stably transfected with pZeoSV2 or pZeoSV2-IB. mRNA from each culture was isolated and compared by PCR select cDNA subtraction. The results showed lower levels of -macroglobulin ( -M) in HepG2X-pZeoSV2 compared to HepG2X-pZeoSV2-IB cells. This was confirmed by Northern and Western blotting, and by measurement of extracellular -M levels. Elevated transforming growth factor-1 (TGF-1) levels were also seen in HepG2X compared to control cells. Serum-free conditioned medium (SFCM) from HepG2X cells suppressed DNA synthesis in a TGF--sensitive cell line, Mv1Lu. The latter was reversed when the SFCM was pretreated with exogenous, activated -M or with anti-TGF-. Since elevated TGF-1 promotes the development of many tumour types, these observations suggest that the HBxAg-mediated alteration in TGF-1 and -M production may contribute importantly to the pathogenesis of HCC.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19650-0
2004-02-01
2019-11-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/2/vir850275.html?itemId=/content/journal/jgv/10.1099/vir.0.19650-0&mimeType=html&fmt=ahah

References

  1. Akhurst, R. J. ( 2002; ). TGF-β antagonists: why suppress a tumor suppressor? J Clin Invest 109, 1533–1536.[CrossRef]
    [Google Scholar]
  2. Armendariz-Borunda, J., Seyer, J. M., Kang, A. H. & Raghow, R. ( 1990; ). Regulation of TGF-β gene expression in rat liver intoxicated with carbon tetrachloride. FASEB J 4, 215–221.
    [Google Scholar]
  3. Bachem, M. G., Riess, U., Melchior, R., Sell, K. M. & Gressner, A. M. ( 1989; ). Transforming growth factor (TGF alpha and TGF beta 1) stimulate chondroitin sulfate and hyaluronate synthesis in cultured rat liver fat storing cells. FEBS Lett 257, 134–137.[CrossRef]
    [Google Scholar]
  4. Beg, A. A. & Baltimore, D. ( 1996; ). An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782–784.[CrossRef]
    [Google Scholar]
  5. Beg, A., Sha, W., Bronson, R., Ghosh, S. & Baltimore, D. ( 1995; ). Embryonic lethality and liver regeneration in mice lacking the RelA component of NF-κB. Nature 376, 167–170.[CrossRef]
    [Google Scholar]
  6. Benn, J. & Schneider, R. J. ( 1994; ). Hepatitis B virus HBX protein activates Ras–GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci U S A 91, 10350–10354.[CrossRef]
    [Google Scholar]
  7. Benson, D. A., Boguski, M. S., Lipman, D. J. & Ostell, J. ( 1997; ). GenBank. Nucleic Acids Res 25, 1–6.[CrossRef]
    [Google Scholar]
  8. Bode, J. G., Fischer, R., Haussinger, D., Graeve, L., Heinrich, P. C. & Schaper, F. ( 2001; ). The inhibitory effect of IL-1 beta on IL-6 induced alpha 2-macroglobulin expression is due to activation of NF-kappa B. J Immunol 167, 1469–1481.[CrossRef]
    [Google Scholar]
  9. Borth, W. ( 1992; ). Alpha-2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J 6, 3345–3353.
    [Google Scholar]
  10. Castilla, A., Prieto, J. & Fausto, N. ( 1991; ). Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alpha therapy. N Engl J Med 324, 933–940.[CrossRef]
    [Google Scholar]
  11. Cross, J. C., Wen, P. & Rutter, W. J. ( 1993; ). Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc Natl Acad Sci U S A 90, 8078–8082.[CrossRef]
    [Google Scholar]
  12. Czaja, M. J., Weiner, F. R., Flanders, K. C., Giambrone, M. A., Wind, R., Biempica, L. & Zern, M. A. ( 1989; ). In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol 108, 2477–2482.[CrossRef]
    [Google Scholar]
  13. Edwards, D. R., Murphy, G. & Reynolds, J. J. ( 1987; ). Transforming growth factor beta modulates the expression of metalloproteinase inhibitor. EMBO J 6, 1899–1904.
    [Google Scholar]
  14. Factor, V. M., Kao, C. Y., Santoni-Rugiu, E., Woitach, J. T., Jensen, M. R. & Thorgeirsson, S. S. ( 1997; ). Constitutive expression of mature transforming growth factor β1 in the liver accelerates hepatocarcinogenesis in transgenic mice. Cancer Res 57, 2089–2095.
    [Google Scholar]
  15. Feitelson, M. A. ( 1999; ). Hepatitis B virus in hepatocarcinogenesis. J Cell Physiol 181, 188–202.[CrossRef]
    [Google Scholar]
  16. Gonias, S. L., LaMarre, J., Crookston, K. P., Webb, D. J., Wolf, B. B., Lopes, M. B., Moses, H. L. & Hayes, M. A. ( 1994; ). α2-macroglobulin and the α2-macroglobulin receptor/LRP: a growth regulatory axis. Ann N Y Acad Sci 737, 273–290.[CrossRef]
    [Google Scholar]
  17. Gressner, A. M. & Bachem, M. G. ( 1995; ). Molecular mechanisms of liver fibrogenesis – a homage to the role of activated fat-storing cells. Digestion 56, 335–346.[CrossRef]
    [Google Scholar]
  18. Gressner, A. M., Lahme, B., Mannherz, H. G. & Polzar, B. ( 1997; ). TGF-β-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J Hepatol 26, 1079–1092.[CrossRef]
    [Google Scholar]
  19. Hall, P. K. & Roberts, R. C. ( 1978; ). Physical and chemical properties of human plasma α2-macroglobulin. Biochem J 171, 27–38.
    [Google Scholar]
  20. Henkler, F. & Koshy, R. ( 1996; ). Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis. J Viral Hepat 3, 109–121.[CrossRef]
    [Google Scholar]
  21. Ignotz, R. A. & Massague, J. ( 1986; ). Transforming growth factor beta stimulates the expression of fibronectin and collagen and their incorporation into extracellular matrix. J Biol Chem 261, 4337–4345.
    [Google Scholar]
  22. Ito, N., Kawata, S., Tamura, S. & 7 other authors ( 1991; ). Elevated levels of transforming growth factor-β messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res 51, 4080–4083.
    [Google Scholar]
  23. Jin, Y. M., Yun, C., Park, C., Wang, H. J. & Cho, H. ( 2001; ). Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases. J Viral Hepat 8, 322–330.[CrossRef]
    [Google Scholar]
  24. Kakumu, S., Ito, Y., Takayanagi, M., Yoshioka, K., Wakita, T., Ishikawa, T., Higashi, Y. & Yang, Z. Q. ( 1993; ). Effect of recombinant human transforming growth factor β1 on immune responses in patients with chronic hepatitis B. Liver 13, 62–68.
    [Google Scholar]
  25. Kekule, A. S., Lauer, U., Weiss, L., Luber, B. & Hofschneider, P. H. ( 1993; ). Hepatitis B virus transactivator HBx uses a tumor promoter signalling pathway. Nature 361, 742–745.[CrossRef]
    [Google Scholar]
  26. Koike, K., Moriya, K., Iino, S., Yotsuyanagi, H., Endo, Y., Miyamura, T. & Kurokawa, K. ( 1994; ). High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19, 810–819.[CrossRef]
    [Google Scholar]
  27. Kondo, T., Sakaguchi, M., Yamada, H. & Namba, M. ( 1998; ). Two dimensional gel electrophoretic analysis of the changes after immortalization of human cells: decrease of intracellular α2-macroglobulin fragment. Electrophoresis 19, 1836–1840.[CrossRef]
    [Google Scholar]
  28. Kortylewski, M., Feld, F., Kruger, K. D., Bahrenberg, G., Roth, R. A., Joost, H. G., Heinrich, P. C., Behrmann, I. & Barthel, A. ( 2003; ). Akt modulates STAT3-mediated gene expression through a FKHR (FOXO1a)-dependent mechanism. J Biol Chem 278, 5242–5249.[CrossRef]
    [Google Scholar]
  29. LaMarre, J., Wollenberg, G. K., Gonias, S. L. & Hayes, M. A. ( 1991; ). Biology of disease. Cytokine binding and clearance properties of proteinase-activated α2-macroglobulins. Lab Invest 65, 3–14.
    [Google Scholar]
  30. Lee, Y. H. & Yun, Y. ( 1998; ). HBx protein of hepatitis B virus activates Jak1-STAT signaling. J Biol Chem 273, 25510–25515.[CrossRef]
    [Google Scholar]
  31. Lee, D. K., Park, S. H., Yi, Y. & 8 other authors ( 2001; ). The hepatitis B virus encoded oncoprotein pX amplifies TGF-β family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev 15, 455–466.[CrossRef]
    [Google Scholar]
  32. Lian, Z., Pan, J., Liu, J., Zhang, S., Zhu, M., Arbuthnot, P., Kew, M. & Feitelson, M. A. ( 1999; ). The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis. Oncogene 18, 1677–1687.[CrossRef]
    [Google Scholar]
  33. Lian, Z., Liu, J., Pan, J., Tufan, N. L. S., Zhu, M., Arbuthnot, P., Kew, M., Clayton, M. M. & Feitelson, M. A. ( 2001; ). A cellular gene up-regulated by hepatitis B virus encoded X antigen promotes hepatocellular growth and survival. Hepatology 34, 146–157.
    [Google Scholar]
  34. McDoniels-Silvers, A. L., Nimri, C. F., Stoner, G. D., Lubet, R. A. & You, M. ( 2002; ). Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res 8, 1127–1138.
    [Google Scholar]
  35. Nagy, P., Schaff, Z. & Lapis, K. ( 1991; ). Immunohistochemical detection of transforming growth factor-β 1 in fibrotic liver disease. Hepatology 14, 269–273.[CrossRef]
    [Google Scholar]
  36. Natoli, G., Avantaggiati, M. L., Chirillo, P., DeMarzio, E., Collepardo, D., Falco, M., Balsano, C. & Levrero, M. ( 1995a; ). Modulation of intracellular signal transduction pathways by the hepatitis B virus transactivator pX. J Hepatol 22, 14–20.[CrossRef]
    [Google Scholar]
  37. Natoli, G., Ianni, A., Costanzo, A., De Petrillo, G., Ilari, I., Chirillo, P., Balsono, C. & Levrero, M. ( 1995b; ). Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene 11, 1157–1164.
    [Google Scholar]
  38. Oshikawa, O., Tamura, S., Kawata, S. & 7 other authors ( 1996; ). The effect of hepatitis B virus X gene expression on response to growth inhibition by transforming growth factor-β1. Biochem Biophys Res Commun 222, 770–773.[CrossRef]
    [Google Scholar]
  39. Pan, J., Duan, L. X., Sun, B. S. & Feitelson, M. A. ( 2001; ). Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-κB. J Gen Virol 82, 171–182.
    [Google Scholar]
  40. Paradis, V., Bieche, I., Dargere, D. & 7 other authors ( 2003; ). Molecular profiling on hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach. Determination of a molecular diagnostic index. Am J Pathol 163, 733–741.[CrossRef]
    [Google Scholar]
  41. Rieder, H., Armbrust, T., Meyer-zum-Buschenfelde, K. H. & Ramadori, G. ( 1993; ). Contribution of sinusoidal endothelial liver cells to liver fibrosis: expression of transforming growth factor beta 1 receptors and modulation of plasmin-generating enzymes by transforming growth factor beta 1. Hepatology 18, 937–944.[CrossRef]
    [Google Scholar]
  42. Sanderson, N., Factor, V., Nagy, P., Kopp, J., Kondaiah, P., Wakefield, L., Roberts, A. B., Sporn, M. B. & Thorgeirsson, S. S. ( 1995; ). Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A 95, 2572–2576.
    [Google Scholar]
  43. Schuftan, G. G. & Bachem, M. G. ( 1999; ). α2-Macroglobulin reduces paracrine- and autocrine-stimulated matrix synthesis of cultured rat hepatic stellate cells. Eur J Clin Invest 29, 519–528.[CrossRef]
    [Google Scholar]
  44. Shih, W. L., Kuo, M. L., Chuang, S. E., Cheng, A. L. & Doong, S. L. ( 2000; ). Hepatitis B virus X protein inhibits transforming growth factor-β-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem 275, 25858–25864.[CrossRef]
    [Google Scholar]
  45. Song, B. C., Chung, Y. H., Kim, J. A. & 7 other authors ( 2002; ). Transforming growth factor-β1 as a useful serologic marker of small hepatocellular carcinoma. Cancer 94, 175–180.[CrossRef]
    [Google Scholar]
  46. Sottrup-Jensen, L. ( 1989; ). Alpha-2 macroglobulins: structure, shape and mechanism of proteinase complex formation. J Biol Chem 264, 11539–11542.
    [Google Scholar]
  47. Su, F. & Schneider, R. J. ( 1996; ). Hepatitis B virus HBx protein activates transcription factor NF-κB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol 70, 4558–4566.
    [Google Scholar]
  48. Teicher, B. A. ( 2001; ). Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metastasis Res 20, 133–143.[CrossRef]
    [Google Scholar]
  49. Tiggelman, A. M., Linthorst, C., Boers, W., Brand, H. S. & Chamuleau, R. A. ( 1997; ). Transforming growth factor-β-induced collagen synthesis by human liver myofibroblasts is inhibited by α2-macroglobulin. J Hepatol 26, 1220–1228.[CrossRef]
    [Google Scholar]
  50. Twu, J. S., Rosen, C. A., Haseltine, W. A. & Robinson, W. S. ( 1989; ). Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X. J Virol 63, 2857–2860.
    [Google Scholar]
  51. Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A. & Jay, G. ( 1995; ). Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 9, 41–47.[CrossRef]
    [Google Scholar]
  52. Umans, L., Serneels, L., Overbaugh, L., Lorent, K., Van Leuven, F. & Van den Berghe, H. ( 1995; ). Targeted inactivation of the mouse α2-macroglobulin gene. J Biol Chem 270, 19778–19785.[CrossRef]
    [Google Scholar]
  53. Wada, I., Kanada, H., Nomura, K., Kato, Y., Machinami, R. & Kitagawa, T. ( 1999; ). Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor. Hepatology 29, 1718–1721.[CrossRef]
    [Google Scholar]
  54. Webb, D. J., Wen, J., Lysiak, J. J., Umans, L., Van Leuver, F. & Gonias, S. L. ( 1996; ). Murine α-macroglobulins demonstrate divergent activities as neutralizers of transforming growth factor β and as inducers of nitric oxide synthesis. J Biol Chem 271, 24982–24988.[CrossRef]
    [Google Scholar]
  55. Webb, D. J., Wen, J., Karns, L. R., Kurilla, M. G. & Gonias, S. L. ( 1998; ). Localization of binding site for transforming growth factor-β in human α2-macroglobulin to a 20-KDa peptide that also contains the bait region. J Biol Chem 273, 13339–13346.[CrossRef]
    [Google Scholar]
  56. Williams, S. E., Kounnas, M. Z., Argraves, K. M., Argraves, W. S. & Strickland, D. K. ( 1994; ). The α2-macroglobulin receptor/low density lipoprotein receptor protein and the receptor-associated protein: an overview. Ann N Y Acad Sci 737, 1–13.[CrossRef]
    [Google Scholar]
  57. Yamada, T., De Souza, A. T., Finkelstein, S. & Jirtle, R. L. ( 1997; ). Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci U S A 94, 10351–10355.[CrossRef]
    [Google Scholar]
  58. Yoo, Y. D., Ueda, H., Park, K., Flanders, K. C., Lee, Y. I., Jay, G. & Kim, S. J. ( 1996; ). Regulation of transforming growth factor-β1 expression by the hepatitis B virus (HBV) X transactivator. J Clin Invest 97, 388–395.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19650-0
Loading
/content/journal/jgv/10.1099/vir.0.19650-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error